Reliant FORM 10-K Medical Alarms User Manual


 
Consolidated Statement of Operations for the year ended December 31, 2001
F-20
As previously
reported Adjustments As restated
Revenues $ 17,408 $ 1,492 $ 18,900
Cost of revenues 14,014 598 14,612
Gross profit 3,394 894 4,288
Selling, general and administrative expense 5,809 302 6,111
Research and develo
p
ment ex
p
ense 3,202 (86) 3,116
In-process research and development expense 15 15
Amortization of intangibles
Acquired technology and other 806 806
Goodwill 4,149 (91) 4,058
Deferred stock option compensation 109 139 248
Special charges
Goodwill impairment 12,121 (695) 11,426
Other special charges 3,540 (150) 3,390
(Gain) loss on sale of businesses and assets 112 26 138
Operating earnings (loss) (26,469) 1,449 (25,020)
Other income (expense) — net (388) (118) (506)
Interest expense
Lon
g
-term deb
t
(204) (4) (208)
Other (115) 12 (103)
Earnings (loss) from continuing operations before income taxes, minority interests and equity in net loss of associated
companies (27,176) 1,339 (25,837)
Income tax benefit (expense) 3,152 (401) 2,751
(24,024) 938 (23,086)
Minority interests — net of tax
(34) (34)
Equity in net loss of associated companies — net of tax (150) (150)
Net earnings (loss) from continuing operations (24,174) 904 (23,270)
Net earnings (loss) from discontinued operations — net of tax (2,996) 529 (2,467)
Net earnings (loss) before cumulative effect of accounting changes (27,170) 1,433 (25,737)
Cumulative effect of accounting change — net of tax 15 15
Net earnings (loss) $ (27,155) $ 1,433 $ (25,722)
Basic earnings (loss) per common share
— from continuing operations $ (7.58) $ 0.28 $ (7.30)
— from discontinued o
p
erations (0.94) 0.16 (0.78)
Basic earnings (loss) per common share $ (8.52) $ 0.44 $ (8.08)
Diluted earnings (loss) per common share
— from continuing operations $ (7.58) $ 0.28 $ (7.30)
— from discontinued operations (0.94) 0.16 (0.78)
Diluted earnings (loss) per common share $ (8.52) $ 0.44 $ (8.08)